Nebula Genomics
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
711 Stewart Ave Ste 200, Garden City, Ne...Website
www.nebula.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
3
1
1
1
1
About Nebula Genomics
Nebula Genomics specializes in advanced DNA testing through its 30x Whole Genome Sequencing service, allowing customers to decode their entire genetic makeup. Founded in 2018, the company offers products designed for individuals interested in understanding their health, ancestry, and genomic data, with a strong focus on privacy and data security. Nebula Genomics serves both individual consumers and business clients who seek to enhance their lifestyle through personalized insights on diet, exercise, and overall well-being based on genetic information. The company operates from multiple locations and aims to democratize access to personal genomics while contributing to ongoing genomic research in the business services and R&D sector.Explore more
Nebula Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nebula Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Nebula Genomics has new funding data
Check out if Nebula Genomics is spiking on competitors!
Nebula Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Nebula Genomics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nebula Genomics had a recent Job posting/layoffs
Earning: See what the market has to say on Nebula Genomics recently announced quarterly report
Product Launch: Get notified when Nebula Genomics launches new products
Congratulate Masked Content for being promoted to Masked Content at Nebula Genomics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Nebula Genomics
Compare insights from companies similar to Nebula Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nebula Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nebula Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nebula Genomics.
Nebula Genomics financials insights
Gather financial insights about Nebula Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Nebula Genomics Tech Stack
A closer look at the technologies used by Nebula Genomics
See more technologies
Most Recent Scoops
New Hire
Executive Move
Mergers & Acquisitions (M&A)
Funding
Nebula Genomics has received an SBA PPP loan for $150,000-350,000 from Bank of America, supporting the retention of 10 jobs.
Funding
Nebula Genomics News & Media
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
Garden City, NY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics, therapeutics and diagnostics company, today reported that Jason Karkus, one of the driving forces behind ProPhase Diagnostics, becomes President of Nebula Genomics, a wholly-owned subsidiary of ProPhase Labs.The Future of Blockchain Technology in Synthetic Biology - OODA Loop
Synthetic biology is a field that involves the engineering of biological systems to create new organisms or modify existing ones for various applications, such as healthcare, agriculture, and industrial processes. We continue our efforts to understand the risks and opportunities in this exponential industry sector by taking a look at the role blockchain technology will play in synthetic biology, particularly in areas related to data management, security, and collaboration. This research is alsoA Bioinformatician's Perspective on Direct-to-Consumer Whole-Genome Sequencing from Nebula Genomics
A personal assessment of the results from Nebula Genomics' Deep Whole Genome Sequencing product - mfasold.netProPhase Labs’ Nebula Genomics Subsidiary Introduces Lowest Ever NGS Pricing of $249 for its Whole Genome Sequencing DNA Test
Company Provides Update on Significant Progress at Nebula Genomics Subsidiary
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nebula Genomics
Sign Up For FreeTo access detailed company insights
Nebula Genomics specializes in advanced DNA testing through its 30x Whole Genome Sequencing service, allowing customers to decode their entire genetic makeup. Founded in 2018, the company offers products designed for individuals interested in understanding their health, ancestry, and genomic data, with a strong focus on privacy and data security. N... Read More
